One genetic switch could turn pancreatic cells into insulin makers

Scientists silenced a single gene in ductal cells and watched them transform into insulin-producing beta cells at eight times the normal rate.

By ·

Sep 27, 2026

6 cards · 1m 50s · tap to begin

From · · · 1m 50s

One genetic switch could turn pancreatic cells into insulin makers

Scientists silenced a single gene in ductal cells and watched them transform into insulin-producing beta cells at eight times the normal rate.

In brief

Scientists silenced a single gene in ductal cells and watched them transform into insulin-producing beta cells at eight times the normal rate. Harvard researchers silenced the ALDH3B2 gene in pancreatic ductal cells, causing them to become insulin-producing beta cells at higher rates, offering a potential new diabetes…

The insulin shortage in diabetes

Artist illustration of insulin activating glucose transport into a cell by binding to insulin receptors

A healthy pancreas contains about a billion beta cells that produce insulin. In people with diabetes, these cells are missing or broken, so scientists are searching for ways to replace them.

Ductal cells hint at a solution

Researchers at Harvard Medical School discovered that pancreatic ductal cells occasionally transform into beta cells on their own, an unusual ability in adult cells. This suggested they could be engineered to do it more reliably.

Finding the genetic switch

Jian Li, a postdoctoral researcher at Harvard Medical School, led a study using a genetic screen to identify which genes drive the transformation. The team systematically disabled genes across the genome to find the key ones.

Silencing ALDH3B2 boosts transformation

Silencing ALDH3B2 boosts transformation

When researchers silenced the ALDH3B2 gene, ductal cells transformed into beta-like cells at about eight point five percent, compared to fewer than one percent without the alteration. The effect was published in Science Translational Medicine.

Proof in mice with diabetes

The team transplanted altered human cells into mice with diabetes. Human insulin circulated in the animals and their glucose levels dropped to near-normal levels, an effect that persisted for six weeks.

Next steps and remaining challenges

Jian Li said the team must first verify how ALDH3B2 drives the transformation, then test gene therapy or small molecules to inhibit it. Precision is critical because ALDH3B2 is used by many cells throughout the body.

“That's the part we need to verify first. Then, the next step is either gene therapy or to find specific small molecules to inhibit this gene to see if we can achieve a similar, or even better, effect.”

What to remember

Harvard researchers silenced the ALDH3B2 gene in pancreatic ductal cells, causing them to become insulin-producing beta cells at higher rates, offering a potential new diabetes treatment approach.

Read the original on WIRED

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on diabetes treatment and related topics.